论文信息 - NRAS mutation: A potential biomarker of clinical response to immune-based therapies in metastatic melanoma (MM). - 字舞流文

NRAS mutation: A potential biomarker of clinical response to immune-based therapies in metastatic melanoma (MM).

A. Iafrate | R. Sullivan | J. Sosman | G. Ayers | Douglas B. Johnson | C. Lovly | R. Carvajal | Zhiguo Zhao | W. Iams | M. Flavin | Elizabeth Berry | Charles R. Terry